Innovative research into DNA nanotechnology has been submitted to the journal, Nanomedicine: Nanotechnology, Biology and Medicine, comprising intelligent aptamer-incorporated DNA nanonetwork (Apt-Nnes). This novel technology can be used for imaging cancers as well as for increased drug delivery of chemotherapeutics.
The Need for DNA Nanotechnology
Nanoscale materials, which include materials that are within the nanoscale of 1 and 100 nm in size, have gained traction with the integration of nanotechnology into biomedical research.
Nanomaterials such as nanoparticles and nanocarriers have proven to have great potential when delivering drugs to target sites as they allow increased precision of drug release with a high concentration in the target areas. This also reduces systemic effects including toxicity, which is a major concern for chemotherapy drugs used for cancer therapeutics. The biodistribution of these drugs is non-specific and can cause secondary medical issues such as the elimination of healthy cells and tissue, and even affect organ functioning.
While there have been nanomaterials developed for this application such as liposomes and nanoparticles, these can also be associated with obstacles and limitations including the requirement of extensive surface functionalization to aid targetability as well compatibility with the immune system.
These drawbacks have increased research into DNA nanotechnology. This sector has illustrated benefits such as higher suitability for use in vivo as well as a high level of programmability. These advantages have made DNA nanotechnologies like aptamers potentially more suitable for use in cancer diagnostics and therapeutics such as bioimaging, biosensors and drug carriers.
Aptamers
Aptamers can be described as being short single-stranded oligonucleotides, which are usually 20-60 nucleotides long, with the ability to bind to target molecules with a high level of specificity and affinity.
These DNA molecules can bind a wide range of targets such as simple inorganic molecules, large proteins, and cells, as well as being cheaper nucleotide analogues of antibodies. This can enable aptamers to be used as a more cost-effective alternative, with the added benefit of being easily produced and non-toxic.
Applications of aptamer within DNA nanotechnology have led to innovative research into its suitability for cancer research and therapy.
Innovative Research
The pre-print article submitted to the journal Nanomedicine: Nanotechnology, Biology and Medicine has undertaken research to develop a simplistic approach for constructing a versatile aptamer-incorporated DNA nanonetwork (Apt-Nnes) for carrying and delivering drugs with increased targetability.
This research has been developed for the application of carrying chemotherapy drugs such as doxorubicin (Dox), which can be loaded onto the Apt-Nnes carrier. This drug delivery carrier has a high cargo loading capacity as well as being suitable for biological systems without causing immunity issues or resulting in toxicity.
Additionally, the targetability of this DNA technology was tested for its potential use in cancer therapeutics by evaluating its specificity for the protein tyrosine kinase 7, which is overexpressed in T-cell acute lymphoblastic leukemia. The results of this research consisted of finding the binding affinity of this drug delivery carrier was heavily enhanced through the use of multivalent aptamers. Additionally, the structure itself was suitable for its purpose as its structural integrity was maintained in fetal bovine serum for eight hours.
The small size of this drug delivery carrier enables natural interaction with cancer cells, and this can allow its cancer-specific receptors to detect and enter cancer cells before releasing the chemotherapy drug with a high concentration within a localized area. Cytotoxicity within a localized tumor site using this DNA nanotechnology allow the preservation of heathy cells and tissue within the patient and this lack of systemic toxicity can allow patients to experience fewer adverse effects.
Future Outlook
Utilizing aptamers, this nano-based method can also enable a more patient-centered treatment approach, which can include potentially fewer chemotherapy treatment sessions, especially if sustained drug release can be enabled. The use of smaller doses of the chemotherapy drug is also a possibility with the drug being released in the target area, a larger dose is no longer required to ensure the site is reached. This can be beneficial for health care systems as the requirement of the overall drug treatment dose per patient is reduced and there this can be cheaper for the hospital, allowing the treatment of a larger number of patients.
The quality of life of these patients that are able to experience reduced toxicity is also a benefit of this novel approach and with further research, this research, while in its infancy, may be able to enter clinical practice and increase patient care.
News
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
Scientists Uncover Hidden Blood Pattern in Long COVID
Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms. Researchers examining Long COVID have identified a structural connection between circulating microclots and neutrophil extracellular traps (NETs). The [...]
This Cellular Trick Helps Cancer Spread, but Could Also Stop It
Groups of normal cbiells can sense far into their surroundings, helping explain cancer cell migration. Understanding this ability could lead to new ways to limit tumor spread. The tale of the princess and the [...]
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]
